Cerebrospinal fluid (CSF) proteins [amyloid-β (Aβ) protein, total Tau (Tau), and phosphorylated Tau (p-Tau)] and functional and anatomical neuroimaging findings represent the most studied biomarkers of AD. The gene discussed is MAPT; the disease is Alzheimer disease.